Claim · model-written summary
Compound 1 inhibited violacein production by 84.92% in the bacterial bioassay.
Verbatim
e0“In bioassays against Chromobacterium violaceum ATCC 12472, compounds 1, 4, 6, 7 and 9 exhibited potential quorum sensing (QS) inhibitory activity at 250 μM, with violacein inhibition rates of 84.92%, 74.96%, 70.47%, 71.43% and 76.87%, respectively.”
Title
Qiu-Ying He; Sheng-Qiang Yang; Yik-Ling Chew; et al. Journal of Asian Natural Products Research 2026. doi:10.1080/10286020.2026.2658493
Other claims from this paper (8)
- Observation Three undescribed xanthonolignoids were isolated from Hypericum curvisepalum.
- Observation Eight known analogs were isolated from Hypericum curvisepalum.
- Observation Compound 4 inhibited violacein production by 74.96% in the bacterial bioassay.
- Observation Compound 6 inhibited violacein production by 70.47% in the bacterial bioassay.
- Observation Compound 7 inhibited violacein production by 71.43% in the bacterial bioassay.
- Observation Compound 9 inhibited violacein production by 76.87% in the bacterial bioassay.
- Observation The three new compounds inhibited bacterial biofilm formation with dose.
- Observation The three new compounds suppressed bacterial swimming and swarming motility.
Chromobacterium violaceum